FDA finds no link between obesity drugs and suicidal thoughts

The FDA announced popular obesity and Type 2 diabetes medications do not have a clear risk of patients developing depression and suicidal thoughts.

Related Keywords

United States ,Washington ,Denmark ,Danish ,American ,Eli Lilly ,Novo Nordisk ,Drug Administration ,Event Reporting System ,Washington Examiner ,Sentinel System ,